Switzerland
· Delayed Price · Currency is CHF Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of CHF 190.20 billion. The enterprise value is 211.61 billion.
| Market Cap | 190.20B |
| Enterprise Value | 211.61B |
Important Dates
The next estimated earnings date is Thursday, July 17, 2025.
| Earnings Date | Jul 17, 2025 |
| Ex-Dividend Date | Mar 11, 2025 |
Share Statistics
Novartis AG has 1.96 billion shares outstanding. The number of shares has decreased by -2.90% in one year.
| Current Share Class | 1.96B |
| Shares Outstanding | 1.96B |
| Shares Change (YoY) | -2.90% |
| Shares Change (QoQ) | -1.25% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 39.49% |
| Float | 1.87B |
Valuation Ratios
The trailing PE ratio is 17.22 and the forward PE ratio is 14.00. Novartis AG's PEG ratio is 1.77.
| PE Ratio | 17.22 |
| Forward PE | 14.00 |
| PS Ratio | 4.04 |
| PB Ratio | 5.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.22 |
| P/OCF Ratio | 11.33 |
| PEG Ratio | 1.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.72, with an EV/FCF ratio of 13.60.
| EV / Earnings | 18.62 |
| EV / Sales | 4.50 |
| EV / EBITDA | 10.72 |
| EV / EBIT | 13.49 |
| EV / FCF | 13.60 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.81.
| Current Ratio | 0.79 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 1.40 |
| Debt / FCF | 1.78 |
| Interest Coverage | 16.83 |
Financial Efficiency
Return on equity (ROE) is 32.89% and return on invested capital (ROIC) is 16.23%.
| Return on Equity (ROE) | 32.89% |
| Return on Assets (ROA) | 11.42% |
| Return on Invested Capital (ROIC) | 16.23% |
| Return on Capital Employed (ROCE) | 25.98% |
| Revenue Per Employee | 619,975 |
| Profits Per Employee | 149,793 |
| Employee Count | 75,883 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.24 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.73% in the last 52 weeks. The beta is 0.53, so Novartis AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +2.73% |
| 50-Day Moving Average | 92.74 |
| 200-Day Moving Average | 94.86 |
| Relative Strength Index (RSI) | 66.47 |
| Average Volume (20 Days) | 3,221,230 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of CHF 47.05 billion and earned 11.37 billion in profits. Earnings per share was 5.64.
| Revenue | 47.05B |
| Gross Profit | 35.60B |
| Operating Income | 15.69B |
| Pretax Income | 13.19B |
| Net Income | 11.37B |
| EBITDA | 19.52B |
| EBIT | 15.69B |
| Earnings Per Share (EPS) | 5.64 |
Balance Sheet
The company has 6.31 billion in cash and 27.64 billion in debt, giving a net cash position of -21.33 billion or -10.89 per share.
| Cash & Cash Equivalents | 6.31B |
| Total Debt | 27.64B |
| Net Cash | -21.33B |
| Net Cash Per Share | -10.89 |
| Equity (Book Value) | 33.99B |
| Book Value Per Share | 17.31 |
| Working Capital | -5.76B |
Cash Flow
In the last 12 months, operating cash flow was 16.79 billion and capital expenditures -1.23 billion, giving a free cash flow of 15.56 billion.
| Operating Cash Flow | 16.79B |
| Capital Expenditures | -1.23B |
| Free Cash Flow | 15.56B |
| FCF Per Share | 7.94 |
Margins
Gross margin is 75.68%, with operating and profit margins of 33.35% and 24.16%.
| Gross Margin | 75.68% |
| Operating Margin | 33.35% |
| Pretax Margin | 28.03% |
| Profit Margin | 24.16% |
| EBITDA Margin | 41.50% |
| EBIT Margin | 33.35% |
| FCF Margin | 33.08% |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.61%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 3.61% |
| Dividend Growth (YoY) | -56.79% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 60.27% |
| Buyback Yield | 2.90% |
| Shareholder Yield | 6.51% |
| Earnings Yield | 5.98% |
| FCF Yield | 8.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 7, 2001. It was a forward split with a ratio of 40.
| Last Split Date | May 7, 2001 |
| Split Type | Forward |
| Split Ratio | 40 |
Scores
Novartis AG has an Altman Z-Score of 3.71.
| Altman Z-Score | 3.71 |
| Piotroski F-Score | n/a |